AcuityBio Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

AcuityBio General Information

Description

Developer of bio-compatible and biodegradable drug-eluting surgical products designed to commercialize novel polymer drug delivery technologies. The company's products are implemented with safety and efficacy in preclinical models, long-term targeted delivery of therapeutic levels of paclitaxel to areas at highest risk for harboring residual cancer cells and can be applied to additional indications besides lung cancer, enabling surgeons to administer during initial tumor removal surgery and prevent a recurrence.

Contact Information

Website
www.acuitybio.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 321 Walnut Street
  • Suite 300
  • Newton, MA 02460
  • United States
+1 (617)
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Acquirer
Cook Biotech
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 321 Walnut Street
  • Suite 300
  • Newton, MA 02460
  • United States
+1 (617)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AcuityBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 01-Jun-2021 Completed Generating Revenue
6. Later Stage VC 10-Feb-2020 Completed Generating Revenue
5. Later Stage VC (Series A) 13-Nov-2017 Completed Generating Revenue
4. Grant Completed Generating Revenue
3. Grant 01-Jul-2013 Completed Generating Revenue
2. Grant 16-Sep-2011 $1.4M Completed Generating Revenue
1. Grant 01-Jan-2008 $500K Completed Startup
To view AcuityBio’s complete valuation and funding history, request access »

AcuityBio Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view AcuityBio’s complete cap table history, request access »

AcuityBio Patents

  • 18

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

AcuityBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2989171-A1 Implantable drug delivery compositions and methods of use thereof Pending 18-Jun-2015
AU-2016280274-B2 Implantable drug delivery compositions and methods of use thereof Active 18-Jun-2015
AU-2016280274-A1 Implantable drug delivery compositions and methods of use thereof Active 18-Jun-2015
US-20180193282-A1 Implantable drug delivery compositions and methods of use thereof Active 18-Jun-2015
JP-2021107420-A Implantable drug delivery compositions and methods of use thereof Pending 18-Jun-2015 A61K9/0024
To view AcuityBio’s complete patent history, request access »

AcuityBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AcuityBio Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Internal Revenue Service Government
National Cancer Institute Government
U.S. Department of Health and Human Services Government
To view AcuityBio’s complete investors history, request access »

Ready to get started?

Request a free trial

AcuityBio FAQs

  • When was AcuityBio founded?

    AcuityBio was founded in 2008.

  • Where is AcuityBio headquartered?

    AcuityBio is headquartered in Newton, MA.

  • What is the size of AcuityBio?

    AcuityBio has 3 total employees.

  • What industry is AcuityBio in?

    AcuityBio’s primary industry is Drug Delivery.

  • Is AcuityBio a private or public company?

    AcuityBio is a Private company.

  • What is AcuityBio’s current revenue?

    The current revenue for AcuityBio is .

  • How much funding has AcuityBio raised over time?

    AcuityBio has raised $2.83M.

  • Who are AcuityBio’s investors?

    Internal Revenue Service, National Cancer Institute, and U.S. Department of Health and Human Services have invested in AcuityBio.

  • When was AcuityBio acquired?

    AcuityBio was acquired on 01-Jun-2021.

  • Who acquired AcuityBio?

    AcuityBio was acquired by Cook Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »